Cantor Equity Partners VI (CEPS) vs Oaktree Acquisition III Life Sciences (OACC)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Cantor Equity Partners VI is the larger company by market cap ($148.4 million vs $141.9 million), about 1.0 times the size. On valuation, Oaktree Acquisition III Life Sciences trades at a lower trailing P/E (59.5x vs 63.2x for Cantor Equity Partners VI).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CEPS | OACC |
|---|---|---|
| Share price | $10.11 | $10.71 |
| Market cap | $148.36M | $141.93M |
| 1-day change | -0.10% | -0.19% |
| YTD return | — | +1.23% |
| 1-year return | — | +1.42% |
| P/E ratio (TTM) | 63.19 | 59.50 |
| EPS (TTM) | $0.16 | $0.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-63.56K | $7.29M |
| 52-week high | $10.45 | $10.93 |
| 52-week low | $10.05 | $10.50 |
| Distance from 52-week high | -3.25% | -2.01% |
| Average volume | 38.77K | 28.11K |
| Shares outstanding | 11.80M | 13.25M |
| Sector | Finance | Finance |
| Industry | Blank Checks | Blank Checks |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Cantor Equity Partners VI
CEPS stock →Cantor Equity Partners VI, Inc. focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
Finance · Blank Checks
About Oaktree Acquisition III Life Sciences
OACC stock →Oaktree Acquisition Corp. III Life Sciences does not have significant operations.
Finance · Blank Checks
CEPS vs OACC FAQ
Which is bigger, Cantor Equity Partners VI or Oaktree Acquisition III Life Sciences?
Cantor Equity Partners VI (CEPS) is larger, with a market capitalization of $148.36M compared with $141.93M for Oaktree Acquisition III Life Sciences (OACC).
Which has the lower P/E ratio, CEPS or OACC?
OACC has the lower trailing P/E at 59.5, versus 63.2 for CEPS. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Are Cantor Equity Partners VI and Oaktree Acquisition III Life Sciences in the same industry?
Yes. Both are classified in the Blank Checks industry within the Finance sector.